MAPK3 and pulmonary fibrosis: A recent study showed that lncRNAPCAT29 inhibits pulmonary fibrosis via downregulating RASAL1/ERK1/2 signal pathway, which suppresses the expression levels of MMP2 and MMP9 in alveolar epithelial cells and pulmonary fibroblast cell differentiation (40).